Post Profile






What some stories missed about the muscular dystrophy drug approval: Pharma’s close ties to vocal patient advocacy groups

Dr. Susan Molchan is a psychiatrist in the Washington D.C. area who contributes regularly to HealthNewsReview.org. She has been a clinical researcher at the National Institutes of Health and was a medical officer at the Food and Drug Administration.  Many news stories about the Food and Drug Administration’s (FDA) Sept. 19 approval of the first drug […] The post What some stories missed about the muscular dystrophy drug approval: Pharma’s close ties to vocal patient advocacy groups appeared first on HealthNewsReview.
read more

share

Related Posts


NFL-affiliated neurosurgeon downplays concussion risks in Penn State news release

Health : Health News Watchdog blog

The following is a guest blog post from one of our regular contributors and reviewers, Susan Molchan, MD, a psychiatrist in the Washington, DC, area. Over the past several years many stories in the media, as well as last winter’s mo...

Sarepta's keenly watched muscle dystrophy drug wins FDA approval

Health : Reuters: Health

(Reuters) - Sarepta Therapeutics Inc's Duchenne muscular dystrophy drug won approval from the U.S. Food and Drug Administration on Monday, capping months of regulatory uncertainty and pressure from parents and patient advocates to e...

What’s at stake in the FDA’s decision on eteplirsen, an experimental muscular dystrophy drug

Health : Health News Watchdog blog

The following guest post is by Susan Molchan, MD, one of our regular contributors, who has previously worked at the FDA. She tweets as @SusanMolchan. One of the functions of the Food and Drug Administration (FDA) and related agencie...

Why news media speculation over Trump’s mental health needs to stop

Health : Health News Watchdog blog

The following is a guest blog post from one of our regular contributors and reviewers, Susan Molchan, MD, a psychiatrist in the Washington, DC area, who also has worked as a scientist at the National Institute of Mental Health. “Wit...

Our psychiatrist-reviewer analyzes news about proton pump inhibitors & dementia risk

Health : Health News Watchdog blog

Guest post by Dr. Susan Molchan, a psychiatrist with extensive experience in clinical research at the National Institutes of Health. She is the former program director for clinical dementia research at the National Institute on Agin...

Comments


Copyright © 2016 Regator, LLC